|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.78 USD | +0.98% |
|
+11.51% | -0.90% |
| Market Cap | 3.6B 3.15B 2.9B 2.69B 5.1B 344B 5.19B 34.78B 13.63B 169B 13.51B 13.22B 584B | P/E 2026 * |
233x | P/E 2027 * | 28.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.34B 2.92B 2.69B 2.49B 4.73B 318B 4.8B 32.22B 12.63B 156B 12.52B 12.25B 542B | EV / Sales 2026 * |
6.69x | EV / Sales 2027 * | 4.67x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | +0.98% | ||
| 1 week | +11.51% | ||
| Current month | +9.76% | ||
| 1 month | +26.28% | ||
| 3 months | +17.13% | ||
| 6 months | +1.98% | ||
| Current year | -0.90% |
| 1 week | 25.25 |  | 29.84 |
| 1 month | 22.94 | | 29.84 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.7 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 2017-03-31 |
| Corporate Officer/Principal | 71 | 2025-12-02 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 2019-11-30 |
Todd Watanabe
BRD | Director/Board Member | 58 | 2015-12-31 |
Howard Welgus
BRD | Director/Board Member | 74 | 2020-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Sell | Director | -635 | 0.0005% | ||
| 06-14 | Sell | Director | -4,946 | 0.0040% | ||
| 06-04 | Free | Director | 22,445 | 0.0179% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | +11.51% | +102.39% | +211.14% | 3.6B | |
| +0.76% | +2.09% | +20.88% | -3.54% | 67.96B | |
| +0.52% | -5.52% | +46.80% | +219.12% | 54.4B | |
| -2.79% | +32.50% | +32.50% | +32.50% | 40.63B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 41.74B | |
| -0.72% | -7.96% | +49.53% | -27.69% | 29.37B | |
| +3.74% | -4.01% | +133.49% | -35.59% | 30.38B | |
| +1.07% | +1.42% | +72.47% | +90.95% | 23.68B | |
| +4.98% | +3.30% | +13.02% | +204.87% | 19.15B | |
| +1.14% | -0.17% | +68.83% | +135.40% | 17.14B | |
| Average | +0.76% | -0.00% | +49.06% | +77.37% | 32.8B | |
| Weighted average by Cap. | +0.35% | -1.16% | +37.35% | +54.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 499M 436M 402M 372M 706M 47.6B 718M 4.82B 1.89B 23.37B 1.87B 1.83B 80.97B | 646M 565M 521M 482M 916M 61.69B 931M 6.24B 2.45B 30.29B 2.43B 2.37B 105B |
| Net income | 17.06M 14.92M 13.76M 12.73M 24.17M 1.63B 24.57M 165M 64.61M 800M 64.04M 62.66M 2.77B | 135M 118M 109M 101M 191M 12.86B 194M 1.3B 510M 6.32B 506M 495M 21.88B |
| Net Debt | -265M -231M -213M -197M -375M -25.25B -381M -2.56B -1B -12.4B -993M -972M -42.95B | -580M -507M -468M -433M -821M -55.35B -835M -5.6B -2.2B -27.18B -2.18B -2.13B -94.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | US$28.78 | +0.98% | 1,738,482 |
| 26-07-08 | US$28.50 | +3.00% | 1,804,101 |
| 26-07-07 | US$27.67 | +6.14% | 2,397,370 |
| 26-07-06 | US$26.07 | +1.01% | 1,290,402 |
| 26-07-02 | US$25.81 | -0.12% | 1,198,181 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
